Albemarle Corp. stock slips while 2026 sales guidance is affirmed
π Albemarle Corp. stock closed at $111.02 on September 18, 2026, representing a 3.5% daily decline and a 21.5% drop year-to-date from the opening price of $141.43.
π The company affirmed its 2026 sales guidance between $5.70 billion and $6.00 billion, implying a midpoint revenue target that exceeds recent quarterly performance metrics.
π° In the quarter ended August 5, 2026, Albemarle reported earnings per share of $3.75, beating the consensus estimate of $3.20 by $0.55.
π Revenue for the most recent quarter reached $1.74 billion, marking a 31.1% increase compared to the same quarter in the prior year.
β οΈ Investors are expressing concern over lithium supply constraints, pricing cycles, and necessary capital expenditures despite the company's strong earnings beat.
π Albemarle continues to invest in capacity for energy storage and specialty chemicals while maintaining its full-year 2026 sales guidance range.
- Albemarle Corp. beat analyst consensus estimates for earnings per share by $0.55 in the quarter ended August 5, 2026, reporting $3.75 versus the expected $3.20.
- The company achieved a 31.1% year-over-year revenue increase to $1.74 billion in its most recent quarter, demonstrating strong volume growth and maintained profitability.
- Management has affirmed its full-year 2026 sales guidance between $5.70 billion and $6.00 billion, signaling confidence in continued demand for energy storage and specialty chemicals.
- Albemarle Corp. shares have fallen 21.5% year-to-date from the start-of-year price of $141.43 to a closing price of $111.02 on September 18, 2026.
- Investor sentiment reflects concern regarding lithium supply dynamics, pricing cycles, and capital expenditure needs despite the company's recent earnings beat.